The story of Viagra, formerly marketed by copyright, presents a intricate case study for backers considering the healthcare sector. Despite its groundbreaking success and creation of billions in earnings , the exclusivity lapse has opened the door for generic medications, substantially reducing income opportunities. This change knockoff raises conc